Cargando…
Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial
TLR-9 agonists are immunostimulating agents that have antitumor effects in animal models. A phase I trial was conducted to define the safety profile of subcutaneous injections, combined with intrathecally administration of CpG-28, a TRL 9 agonist, in patients with neoplastic meningitis (NM). Cohorts...
Autores principales: | Ursu, Renata, Taillibert, Sophie, Banissi, Claire, Vicaut, Eric, Bailon, Olivier, Le Rhun, Emilie, Guillamo, Jean-Sebastien, Psimaras, Dimitri, Tibi, Annick, Sacko, Adama, Marantidou, Athina, Belin, Catherine, Carpentier, Antoine F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582991/ https://www.ncbi.nlm.nih.gov/pubmed/26094710 http://dx.doi.org/10.1111/cas.12724 |
Ejemplares similares
-
Carcinomatous meningitis: Leptomeningeal metastases in solid tumors
por: Le Rhun, Emilie, et al.
Publicado: (2013) -
Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model
por: Golali, Ensieh, et al.
Publicado: (2012) -
The effect of CpG-ODN on antigen presenting cells of the foal
por: Flaminio, M Julia BF, et al.
Publicado: (2007) -
Effect of CpG ODN on monocytic myeloid derived suppressor cells
por: Shirota, Hidekazu, et al.
Publicado: (2012) -
TRAIL is involved in CpG ODN-mediated anti-apoptotic signals
por: LIM, EUN-JUNG, et al.
Publicado: (2011)